These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 530724)

  • 1. [Experiences with aldactone in pediatric cardiology (author's transl)].
    Wimmer M; Bachl G; Schlemmer M; Stiskal A
    Padiatr Padol; 1979; 14(4):363-72. PubMed ID: 530724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
    Gorbach HC; Bräuninger HJ
    MMW Munch Med Wochenschr; 1975 Sep; 117(37):1483-6. PubMed ID: 810673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of aldosterone antagonists in juvenile heart surgery].
    Wimmer M; Parth K; Holzer H
    Acta Med Austriaca; 1979; 6(1):8-12. PubMed ID: 506658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary aldosteronism following surgery using the heart-lung machine and its regulation with Aldactone].
    Gleichmann U; Bostroem B; Kreuzer H; Löhr B
    Anaesthesist; 1965 Dec; 14(12):355-9. PubMed ID: 5870012
    [No Abstract]   [Full Text] [Related]  

  • 5. Single-dose i.v. Aldactone for congestive heart failure: a preliminary observation.
    Ceremuzyński L; Budaj A; Michorowski B
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):417-21. PubMed ID: 6629545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aldactone in the treatment of sarcoidosis of the lungs (author's transl)].
    Wandelt-Freerksen E
    Z Erkr Atmungsorgane; 1977 Jul; 149(1):156-9. PubMed ID: 607621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrocardiographic observations in secondary aldosteronism].
    Hilmer W
    Med Klin; 1972 Jan; 67(4):128-33. PubMed ID: 5060139
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperaldosteronism and the use of aldactone in cardiac insufficiency].
    Korochkin IM; Matveeva IV; Sidorenko BA; Arshakuni RO
    Kardiologiia; 1968 Dec; 8(12):74-81. PubMed ID: 5736746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Direct positive inotropic cardiac effect of aldactone (spironolactone, canrenoate-K)].
    Schröder R; Ramdohr B; Hüttemann U; Schüren KP
    Dtsch Med Wochenschr; 1972 Oct; 97(41):1535-8. PubMed ID: 4561711
    [No Abstract]   [Full Text] [Related]  

  • 10. [The aldosterone antagonist spironolactone prolongs the survival of chronic heart failure patients. The results of the RALES study. The Randomized Aldactone Evaluation Study].
    Schwinger RH
    Dtsch Med Wochenschr; 1999 Aug; 124(34-35):987-8. PubMed ID: 10488324
    [No Abstract]   [Full Text] [Related]  

  • 11. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
    Cruz CS; Cruz LS; Domingues GS; Souza CA
    Expert Opin Drug Saf; 2005 Jul; 4(4):677-88. PubMed ID: 16011447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic experience with osyrol 100/Lasix in the treatment of congestive heart failure (author's transl)].
    Freude J
    MMW Munch Med Wochenschr; 1979 Jun; 121(24):827-30. PubMed ID: 111084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of traumatic brain edema with spironolactone (author's transl)].
    Oberbauer R; Heppner F; Auer L
    Wien Med Wochenschr; 1979 Mar; 129(5):140-3. PubMed ID: 373262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists.
    Haschke F; Wimmer M; Parth K
    Padiatr Padol; 1981; 16(3):317-26. PubMed ID: 7254888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary hyperaldosteronism as a secondary disease in intractable cardiac decompensation].
    Antalóczy Z; Ludvigh G
    Z Arztl Fortbild (Jena); 1965 Jul; 59(14):757-61. PubMed ID: 5887150
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
    Emili M; Cuppone R; Ricci GL
    Arzneimittelforschung; 1988 Oct; 38(10):1492-5. PubMed ID: 3058132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone use in patients with heart failure.
    Trujillo JM; Gonyeau MJ; DiVall MV; Alexander SL
    J Clin Pharm Ther; 2004 Apr; 29(2):165-70. PubMed ID: 15068406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB; Rao K; Sawyer R; Gottlieb SS
    J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of cardiac edemas by a combination of micronized aldactone and Altizide].
    Soulié P; Gaudeau S
    Coeur Med Interne; 1965 Apr; 4(2):209-13. PubMed ID: 5827838
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intolerance to spironolactone in refractory cardiac insufficiency. Probable changes in the aldosterone receptors. Study of 11 cases].
    Sänchez Torres G; Posadas C; Boyer JL; Guzmán Lara J; Serrano P
    Arch Inst Cardiol Mex; 1981; 51(3):233-40. PubMed ID: 6456707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.